Saturday 20 October 2018
Contact US    |    Archive
Stony Brook
2 months ago

First In-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to be Launched

Stony Brook University, iCell Gene Therapeutics, and the University of Louisville, have received Food and Drug Administration (FDA) clearance for an Investigational New Drug (IND) for the treatment of relapsed and refractory T-cell leukemia and lymphoma. T

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

Akademie im Exil

- Duisburg-Essen

Was ist an der Uni los?

- Duisburg-Essen

Das geht mich an!

- Duisburg-Essen

Löhne weiter unter Druck

- Duisburg-Essen

Die Zukunft gestalten

- Duisburg-Essen

Maschine statt Mensch

- Duisburg-Essen
Hashtags:   

First

 | 

Human

 | 

Clinical

 | 

Trial

 | 

Targeting

 | 

CD4

 | 

Protein

 | 

for

 | 

Aggressive

 | 

cell

 | 
Most Popular (6 hours)

Maschine statt Mensch

- Duisburg-Essen

Die Zukunft gestalten

- Duisburg-Essen

Löhne weiter unter Druck

- Duisburg-Essen

Das geht mich an!

- Duisburg-Essen

Was ist an der Uni los?

- Duisburg-Essen

Akademie im Exil

- Duisburg-Essen

Most Popular (24 hours)

HackPrinceton

- Princeton

Of Roads and Homes

- Princeton

Of Roads and Homes

- Princeton

Most Popular (a week)

IUFROkonferens

- Agricultural Sciences

Review: Mandy

- Mancunion